Medical Economic Impact of Daikenchuto in Colon and Rectal Cancer Surgery: A Nationwide Observational Study
Journal of the Anus, Rectum and Colon · 25.10.2026 · 10 (4) · 598-604
DOI: 10.23922/jarc.2026-053 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Anus, Rectum and Colon, erschienen am 25.10.2026. Verfasst von Nobuaki Hoshino und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Daikenchuto is a traditional Japanese herbal medicine (Kampo) that has been widely used because of its low cost and minimal side effects. It is used for early patient recovery after abdominal surgery and to prevent postoperative paralytic ileus in various surgeries, including colon and rectal cancer. Many studies have reported the usefulness of perioperative administration of Daikenchuto; however, few have examined its association with healthcare economics.
Methods
This observational study used data from the National Database (NDB) Sampling Dataset. This study included patients with colon or rectal cancer who underwent colectomy, anterior resection (AR), low anterior resection (LAR), or abdominoperineal resection (APR) between January 2013 and December 2022. The comparison was based on Daikenchuto administration.
Results
Overall, 3,759 patients underwent colectomy (Daikenchuto -: 3,111 vs. Daikenchuto +: 648), 675 underwent AR (567 vs. 108), 1,269 underwent LAR (1,105 vs. 164), and 348 underwent APR (310 vs. 38). Postoperative hospital stay was shorter in patients who received Daikenchuto: for colectomy, 13.8 vs. 13.0 days (P = 0.001); for AR, 15.3 vs. 13.0 days (P = 0.002); for LAR, 17.6 vs. 14.5 days (P < 0.001); and for APR, 22.9 vs. 19.7 days (P = 0.007). Medical costs per patient were lower among patients receiving Daikenchuto by 25,412 yen for colectomy, 68,494 yen for AR, 92,407 yen for LAR, and 94,361 yen for APR.
Conclusion
Perioperative Daikenchuto administration was associated with shortened the length of hospital stay and lower postoperative hospitalization costs in colon and rectal cancer surgeries.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Zitieren
APA
Hoshino, N., Sakamoto, T., Yamamoto, T., Yoshida, Y., Kasahara, K., Okamura, R., Maeda, M., Itatani, Y., Hida, K., & Obama, K. (2026). Medical Economic Impact of Daikenchuto in Colon and Rectal Cancer Surgery: A Nationwide Observational Study. Journal of the Anus, Rectum and Colon, 10(4), 598-604. https://doi.org/10.23922/jarc.2026-053
Vancouver
Hoshino N, Sakamoto T, Yamamoto T, Yoshida Y, Kasahara K, Okamura R, et al. Medical Economic Impact of Daikenchuto in Colon and Rectal Cancer Surgery: A Nationwide Observational Study. Journal of the Anus, Rectum and Colon. 2026;10(4):598-604. doi:10.23922/jarc.2026-053
BibTeX
@article{Hoshino2026,
author = {Hoshino, Nobuaki and Sakamoto, Takashi and Yamamoto, Takehito and Yoshida, Yu and Kasahara, Keiko and Okamura, Ryosuke and Maeda, Masahiro and Itatani, Yoshiro and Hida, Koya and Obama, Kazutaka},
title = {Medical Economic Impact of Daikenchuto in Colon and Rectal Cancer Surgery: A Nationwide Observational Study},
journal = {Journal of the Anus, Rectum and Colon},
year = {2026},
volume = {10},
number = {4},
pages = {598--604},
doi = {10.23922/jarc.2026-053}
}
EUVIMED